(Q44944152)

7 December 2017

Combined therapy with tiotropium and formoterol in chronic obstructive pulmonary disease: effect on the 6-minute walk test (English)

1 reference

chronic obstructive pulmonary disease

7 December 2017

1 reference

Irene Zeng

5

1 reference

7 December 2017

Lata Jayaram

1

1 reference

7 December 2017

Conroy Wong

2

1 reference

7 December 2017

Sue McAuley

3

1 reference

7 December 2017

Harry Rea

4

1 reference

7 December 2017

Conor O'Dochartaigh

6

1 reference

7 December 2017

language of work or name

English

0 references

publication date

5 April 2013

1 reference

COPD: Journal of Chronic Obstructive Pulmonary Disease

7 December 2017

1 reference

7 December 2017

10

1 reference

7 December 2017

4

1 reference

7 December 2017

466-472

1 reference

Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD

7 December 2017

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2013.771162

Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2013.771162

A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2013.771162

Effects of regular salmeterol on lung function and exercise capacity in patients with chronic obstructive airways disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2013.771162

Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2013.771162

Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2013.771162

The functional impact of adding salmeterol and tiotropium in patients with stable COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2013.771162

Use of 6-min and 12-min walking test for assessing the efficacy of formoterol in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2013.771162

Once-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropium

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2013.771162

A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2013.771162

Tiotropium versus salmeterol for the prevention of exacerbations of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2013.771162

Combining tiotropium and salmeterol in COPD: Effects on airflow obstruction and symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2013.771162

Power of outcome measurements to detect clinically significant changes in pulmonary rehabilitation of patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2013.771162

Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2013.771162

The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2013.771162

Standardisation of spirometry

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2013.771162

The role of reference values in interpreting lung function tests.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2013.771162

The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2013.771162

Interpreting thresholds for a clinically significant change in health status in asthma and COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2013.771162

The two-period cross-over clinical trial. 1979

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2013.771162

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2013.771162

Updating the minimal important difference for six-minute walk distance in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2013.771162

Six-minute-walk test in chronic obstructive pulmonary disease: minimal clinically important difference for death or hospitalization

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2013.771162

Comparison of efficacy of long-acting bronchodilators in emphysema dominant and emphysema nondominant chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2013.771162

Single dose of tiotropium improves the 6-minute walk distance in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2013.771162

The effect of tiotropium on hyperinflation and exercise capacity in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2013.771162

Effects of tiotropium and formoterol on dynamic hyperinflation and exercise endurance in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2013.771162

Daily physical activity in patients with chronic obstructive pulmonary disease is mainly associated with dynamic hyperinflation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2013.771162

A qualitative systematic overview of the measurement properties of functional walk tests used in the cardiorespiratory domain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2013.771162

Pulmonary rehabilitation and the BODE index in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2013.771162

Inspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2013.771162

Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2013.771162

Dynamic hyperinflation: is it worth measuring?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2013.771162

Predicting Outcomes from 6-Minute Walk Distance in Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2013.771162

10.3109/15412555.2013.771162

21 January 2018

Identifiers

DOI

1 reference

release_zdf5bgilhvfuxmuv2lhsrht7i4

7 December 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zdf5bgilhvfuxmuv2lhsrht7i4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference